323 related articles for article (PubMed ID: 31397193)
1. Chemotherapy-induced senescence, an adaptive mechanism driving resistance and tumor heterogeneity.
Guillon J; Petit C; Toutain B; Guette C; Lelièvre E; Coqueret O
Cell Cycle; 2019 Oct; 18(19):2385-2397. PubMed ID: 31397193
[TBL] [Abstract][Full Text] [Related]
2. Cellular senescence in the development and treatment of cancer.
Saretzki G
Curr Pharm Des; 2010 Jan; 16(1):79-100. PubMed ID: 20214620
[TBL] [Abstract][Full Text] [Related]
3. Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response.
Elmore LW; Di X; Dumur C; Holt SE; Gewirtz DA
Clin Cancer Res; 2005 Apr; 11(7):2637-43. PubMed ID: 15814644
[TBL] [Abstract][Full Text] [Related]
4. [Contribution to tumor escape and chemotherapy response: A choice between senescence and apoptosis in heterogeneous tumors].
Jonchère B; Vétillard A; Toutain B; Guette C; Coqueret O
Bull Cancer; 2016 Jan; 103(1):73-86. PubMed ID: 26762946
[TBL] [Abstract][Full Text] [Related]
5. Depletion of FOXM1 via MET Targeting Underlies Establishment of a DNA Damage-Induced Senescence Program in Gastric Cancer.
Francica P; Nisa L; Aebersold DM; Langer R; Bladt F; Blaukat A; Stroka D; Martínez MR; Zimmer Y; Medová M
Clin Cancer Res; 2016 Nov; 22(21):5322-5336. PubMed ID: 27185371
[TBL] [Abstract][Full Text] [Related]
6. Cellular senescence and cancer chemotherapy resistance.
Gordon RR; Nelson PS
Drug Resist Updat; 2012; 15(1-2):123-31. PubMed ID: 22365330
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced senescence generates chemoresistant stemlike cells with low reactive oxygen species.
Achuthan S; Santhoshkumar TR; Prabhakar J; Nair SA; Pillai MR
J Biol Chem; 2011 Oct; 286(43):37813-29. PubMed ID: 21878644
[TBL] [Abstract][Full Text] [Related]
8. Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway.
Sun X; Shi B; Zheng H; Min L; Yang J; Li X; Liao X; Huang W; Zhang M; Xu S; Zhu Z; Cui H; Liu X
Cell Death Dis; 2018 Feb; 9(3):260. PubMed ID: 29449532
[TBL] [Abstract][Full Text] [Related]
9. Proteomics Approaches to Define Senescence Heterogeneity and Chemotherapy Response.
Petit C; Guillon J; Toutain B; Boissard A; Patsouris A; Lelièvre E; Guette C; Coqueret O
Proteomics; 2019 Nov; 19(21-22):e1800447. PubMed ID: 30968557
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the PML tumor suppressor in drug-induced senescence of human normal and cancer cells by JAK/STAT-mediated signaling.
Hubackova S; Novakova Z; Krejcikova K; Kosar M; Dobrovolna J; Duskova P; Hanzlikova H; Vancurova M; Barath P; Bartek J; Hodny Z
Cell Cycle; 2010 Aug; 9(15):3085-99. PubMed ID: 20699642
[TBL] [Abstract][Full Text] [Related]
11. tRNA biogenesis and specific aminoacyl-tRNA synthetases regulate senescence stability under the control of mTOR.
Guillon J; Coquelet H; Leman G; Toutain B; Petit C; Henry C; Boissard A; Guette C; Coqueret O
PLoS Genet; 2021 Dec; 17(12):e1009953. PubMed ID: 34928935
[TBL] [Abstract][Full Text] [Related]
12. Regulation of senescence escape by the cdk4-EZH2-AP2M1 pathway in response to chemotherapy.
Le Duff M; Gouju J; Jonchère B; Guillon J; Toutain B; Boissard A; Henry C; Guette C; Lelièvre E; Coqueret O
Cell Death Dis; 2018 Feb; 9(2):199. PubMed ID: 29415991
[TBL] [Abstract][Full Text] [Related]
13. Tumor senescence as a determinant of drug response in vivo.
Roninson IB
Drug Resist Updat; 2002 Oct; 5(5):204-8. PubMed ID: 12450785
[TBL] [Abstract][Full Text] [Related]
14. High COX-2 expression contributes to a poor prognosis through the inhibition of chemotherapy-induced senescence in nasopharyngeal carcinoma.
Shi C; Guan Y; Zeng L; Liu G; Zhu Y; Xu H; Lu Y; Liu J; Guo J; Feng X; Zhao X; Jiang W; Li G; Li G; Dai Y; Jin F; Li W; Zhou W
Int J Oncol; 2018 Sep; 53(3):1138-1148. PubMed ID: 29956730
[TBL] [Abstract][Full Text] [Related]
15. Targeting genes in insulin-associated signalling pathway, DNA damage, cell proliferation and cell differentiation pathways by tocotrienol-rich fraction in preventing cellular senescence of human diploid fibroblasts.
Durani LW; Jaafar F; Tan JK; Tajul Arifin K; Mohd Yusof YA; Wan Ngah WZ; Makpol S
Clin Ter; 2015; 166(6):e365-73. PubMed ID: 26794818
[TBL] [Abstract][Full Text] [Related]
16. Development of rituximab-resistant B-NHL clones: an in vitro model for studying tumor resistance to monoclonal antibody-mediated immunotherapy.
Jazirehi AR; Bonavida B
Methods Mol Biol; 2011; 731():407-19. PubMed ID: 21516425
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity.
Sullivan R; Paré GC; Frederiksen LJ; Semenza GL; Graham CH
Mol Cancer Ther; 2008 Jul; 7(7):1961-73. PubMed ID: 18645006
[TBL] [Abstract][Full Text] [Related]
18. Exploiting cellular senescence to treat cancer and circumvent drug resistance.
Yan Q; Wajapeyee N
Cancer Biol Ther; 2010 Feb; 9(3):166-75. PubMed ID: 20118655
[TBL] [Abstract][Full Text] [Related]
19. Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging.
Muñoz DP; Yannone SM; Daemen A; Sun Y; Vakar-Lopez F; Kawahara M; Freund AM; Rodier F; Wu JD; Desprez PY; Raulet DH; Nelson PS; van 't Veer LJ; Campisi J; Coppé JP
JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31184599
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cells and escape from drug-induced premature senescence in human lung tumor cells: implications for drug resistance and in vitro drug screening models.
Sabisz M; Skladanowski A
Cell Cycle; 2009 Oct; 8(19):3208-17. PubMed ID: 19738435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
